
- 792 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
About this book
Peptide and Peptidomimetic Therapeutics: From Bench to Beside offers applied, evidence-based instruction on developing and applying peptide therapeutics in disease treatment, driving drug discovery, and improving patient care. Here, researchers, clinicians and students will find tools to harness the full power of peptides and peptidomimetics and improve bioavailability, stability, efficiency and selectivity of new therapeutics and their application in treatment plans. More than 20 leaders in the field share their approaches for identifying and advancing peptide and peptidomimetic therapeutics. Topics examined run from "bench to bedside," beginning with fundamental peptide science, protein-protein interactions and peptide synthesis.
Later chapters examine modes for peptide drug delivery, including cell penetration peptide and peptidomimetic delivery, as well as the targeting of specific disease types, peptide therapeutics as applied to infectious disease, cancer, metabolic disorders, neurodegenerative disorders, and skin disorders, and antiparasitic and immunosuppressive peptidomimetics.
- Helps researchers and clinicians harness the full of power of peptides and peptidomimetics in their daily work and drug discovery
- Features chapters running from "bench to bedside, providing a thorough grounding in fundamental peptide science, drug delivery methods, and targeting of specific disease types
- Features chapter contributions from international leaders in peptide science and drug development
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weâve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere â even offline. Perfect for commutes or when youâre on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Peptide and Peptidomimetic Therapeutics by Nir Qvit,Samuel J.S. Rubin in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Biochemistry. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Cover
- Title page
- Table of Contents
- Copyright
- Contents
- List of contributors
- Preface
- List of Illustrations
- List of Tables
- Chapter 1 : Therapeutic peptides: historical perspectives and current development trends
- Chapter 2 : Therapeutic peptidomimetics: targeting the undruggable space
- Chapter 3 : Tailoring peptides and peptidomimetics for targeting proteinâprotein interactions
- Chapter 4 : Advances in peptide synthesis
- Chapter 5 : Stapled peptidomimetic therapeutics
- Chapter 6 : Ring-closing metathesis/transannular cyclization to azabicyclo[X.Y.0]alkanone dipeptide turn mimics for biomedical applications
- Chapter 7 : The current state of backbone cyclic peptidomimetics and their application to drug discovery*
- Chapter 8 : Pharmacokinetics and pharmacodynamics of peptidomimetics
- Chapter 9 : Formulation of peptides and peptidomimetics
- Chapter 10 : Medical use of cell-penetrating peptides: how far have they come?
- Chapter 11 : Intracellular peptides as drug prototypes
- Chapter 12 : Applications of computational three-dimensional structure prediction for antimicrobial peptides
- Chapter 13 : Knottin peptidomimetics as therapeutics
- Chapter 14 : Venom peptides and peptidomimetics as therapeutics
- Chapter 15 : Therapeutic peptides targeting protein kinase: progress, challenges, and future directions, featuring cancer and cardiovascular disease
- Chapter 16 : Therapeutic peptidomimetics for infectious diseases
- Chapter 17 : Antiparasitic therapeutic peptidomimetics
- Chapter 18 : Peptides and antibiotic resistance
- Chapter 19 : Antimicrobial peptides and the skin and gut microbiomes
- Chapter 20 : Peptide and peptidomimetic-based vaccines
- Chapter 21 : Therapeutic peptidomimetics for cancer treatment
- Chapter 22 : Immunomodulatory peptidomimetics for multiple sclerosis therapyâthe story of glatiramer acetate (Copaxone)
- Chapter 23 : Therapeutic peptidomimetics in metabolic diseases
- Chapter 24 : Peptide therapeutics in anesthesiology
- Chapter 25 : Cardiovascular-derived therapeutic peptidomimetics in cardiovascular disease
- Chapter 26 : Noncardiovascular-derived therapeutic peptidomimetics in cardiovascular disease
- Chapter 27 : Clinical and preclinical data on therapeutic peptides
- Chapter 28 : Therapeutic peptides: market and manufacturing
- Chapter 29 : Future perspectives on peptide therapeutics
- Index
- A